"We are UCI Health: A devoted team of nationally regarded physicians and nurses, researchers and clinicians, educators and students united by a single calling to improve the lives of the people in our community and beyond. As the only academic health system in Orange County, our multifaceted organization is dedicated to the discovery of new medical frontiers, to the teaching of future healers and to the delivery of the finest evidence-based care. We are unique in our ability to provide the most compassionate healthcare because were driven by our passion for innovation, grounded in the best medical and scientific knowledge."

During the past decade, University of California Irvine - ALS & Neuromuscular Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California Irvine - ALS & Neuromuscular Center" #1 sponsor was "Cytokinetics" with 2 trials, followed by "ZevraDenmark" with 2 trials sponsored, "aTyr Pharma, Inc." with 2 trials sponsored, "AB Science" with 1 trials sponsored and "Immunovant Sciences GmbH" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "University of California Irvine - ALS & Neuromuscular Center" are "Amyotrophic Lateral Sclerosis" (7 trials), "Facioscapulohumeral Muscular Dystrophy" (2 trials), "Back Pain" (1 trials), "Frontotemporal Dementia" (1 trials) and "Insomnia" (1 trials). Many other conditions were trialed in "University of California Irvine - ALS & Neuromuscular Center" in a lesser frequency.

Most popular intervention types in "University of California Irvine - ALS & Neuromuscular Center" are "Drug" (9 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ATYR1940" (2 trials), "Arimoclomol" (2 trials), "Reldesemtiv" (2 trials) and "Active Mattress Cover" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California Irvine - ALS & Neuromuscular Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "University of California Irvine - ALS & Neuromuscular Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of California Irvine - ALS & Neuromuscular Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of California Irvine - ALS & Neuromuscular Center, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".